2024 AAAAI Annual Meeting

Our presentation of Ox640, Bioavailability and Stability of an Epinephrine Nasal Powder Formulation for Treatment of Anaphylaxis, was selected by the AAAAI program committee to be presented at the late breaking oral abstract session.

The American Academy of Allergy, Asthma & Immunology (AAAAI) is the largest professional medical organization in the United States devoted to the allergy/immunology specialty.

Date: February 23-26, 2024
Presenter: Orexo’s advisor, Dr Anne K Ellis, Professor and Chair of the Division of Allergy & Immunology in the Department of Medicine at Queen’s University (Kingston, Ontario, CA) will give the presentation on behalf of Orexo.
Time: TBD
Address: Washington, DC
Contact: ir@orexo.com